---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-027246"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:43:42.277228+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma announces up to $13M registered direct offering at $1.70/share

## Summary
- $4.7M upfront from sale of 2,764,710 shares at $1.70; closing expected Sep 15, 2025.
- Concurrent private placement of warrants to purchase up to 5,529,420 shares at $1.50, exercisable on issuance, 24-month term.
- Potential additional gross proceeds of ~$8.3M if warrants fully exercised on cash basis.
- H.C. Wainwright & Co. acting as exclusive placement agent.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001641172-25-027246
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000164117225027246/0001641172-25-027246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000164117225027246/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-027246
- JSON: https://secwatch.observer/filing/0001641172-25-027246.json
- Plain text: https://secwatch.observer/filing/0001641172-25-027246.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.